Trulicity vs Ozempic: Which GLP-1 Is Right for You? (2026)

Both Trulicity (dulaglutide) and Ozempic (semaglutide) are GLP-1 receptor agonists used for type 2 diabetes — but they differ significantly in weight loss effectiveness, cardiovascular benefits, and cost. Here’s the full 2026 comparison.

Trulicity vs Ozempic: Quick Comparison

Factor	Trulicity (Dulaglutide)	Ozempic (Semaglutide)
Drug class	GLP-1 receptor agonist	GLP-1 receptor agonist
Manufacturer	Eli Lilly	Novo Nordisk
FDA approval (T2D)	2014	2017
Dosing frequency	Once weekly injection	Once weekly injection
Available doses	0.75mg, 1.5mg, 3mg, 4.5mg	0.25mg, 0.5mg, 1mg, 2mg
Max approved dose (T2D)	4.5mg/week	2mg/week
Average A1C reduction	1.1–1.6%	1.5–1.8%
Average weight loss	3–10 lbs	10–14 lbs (at 1–2mg)
Cardiovascular indication	Yes (REWIND trial)	Yes (SUSTAIN-6 + SELECT trial)
Pen device	Auto-injector, needle hidden	Reusable pen, needle visible
List price (monthly)	~$900–$1,000	~$900–$1,000

Weight Loss: Semaglutide Wins Clearly

The most significant clinical difference is weight loss. In head-to-head trials (SUSTAIN 7), semaglutide 1mg produced greater weight loss than dulaglutide 1.5mg (-4.6 kg vs -2.3 kg) and superior A1C reduction. At higher doses, the gap widens further — semaglutide 2mg outperforms dulaglutide at any available dose for weight outcomes.

For patients whose primary goal is weight loss alongside diabetes management, semaglutide is the stronger choice. If weight loss is the primary goal rather than diabetes, Wegovy (semaglutide 2.4mg) is the appropriate medication — not Ozempic.

Cardiovascular Benefits Comparison

Trial	Drug	Population	Key Outcome
REWIND	Dulaglutide 1.5mg	T2D with CV risk (not all established CVD)	12% reduction in MACE
SUSTAIN-6	Semaglutide 0.5/1mg	T2D with high CV risk	26% reduction in MACE
SELECT	Semaglutide 2.4mg	Overweight/obese, no T2D, established CVD	20% reduction in MACE

Both drugs show cardiovascular benefit, but semaglutide’s SELECT trial is uniquely powerful — it’s the first evidence that a weight loss drug reduces cardiovascular events in non-diabetic patients. This has reshaped how cardiologists view GLP-1 therapy.

Ease of Use: Trulicity Has the Edge

Trulicity uses a single-use auto-injector with a hidden needle — many patients who are needle-phobic find this easier to use. The device automatically injects when pressed against the skin. Ozempic uses a reusable pen where patients attach and see the needle. For those anxious about injections, Trulicity’s device design can be a meaningful advantage.

Side Effects: Very Similar Profile

Side Effect	Trulicity	Ozempic
Nausea	Common (12–21%)	Common (15–20%)
Diarrhea	Common	Less common
Vomiting	Common	Common
Constipation	Less common	More common
Injection site reaction	Rare	Rare
Thyroid warning (MTC)	Yes (black box)	Yes (black box)
Pancreatitis risk	Low	Low

Which Should You Choose?

Choose Ozempic/semaglutide if: weight loss is a major goal, you have established cardiovascular disease and want the strongest CV evidence, or you’re working toward a Wegovy prescription for obesity treatment.

Choose Trulicity/dulaglutide if: you have significant needle anxiety and prefer the hidden-needle auto-injector, or your insurer covers Trulicity more favorably and weight loss is less of a priority.

Is Trulicity Being Discontinued?

There have been supply and market share pressures on Trulicity as semaglutide and tirzepatide have dominated the GLP-1 market. Eli Lilly has shifted focus toward tirzepatide (Mounjaro/Zepbound), which significantly outperforms dulaglutide on both A1C reduction and weight loss. As of 2026, Trulicity remains available but has declining market share. Patients on Trulicity who want better weight loss results are increasingly being transitioned to semaglutide or tirzepatide.

Frequently Asked Questions

Is Trulicity stronger than Ozempic?
No — semaglutide (Ozempic/Wegovy) consistently outperforms dulaglutide (Trulicity) in head-to-head trials for both A1C reduction and weight loss. Ozempic is considered the stronger option for most patients.

Can I switch from Trulicity to Ozempic?
Yes. Switching between GLP-1 receptor agonists is common. Your prescriber will typically start you at a lower initiating dose of semaglutide and titrate up, regardless of what dose of Trulicity you were on.

Does Trulicity cause weight loss like Ozempic?
Some weight loss, but significantly less. Trulicity typically produces 3–10 lbs of weight loss, while Ozempic at 1–2mg produces 10–14 lbs on average. Wegovy (2.4mg semaglutide) produces 15–35 lbs.

Is Trulicity cheaper than Ozempic?
List prices are similar (~$900–$1,000/month). Generic versions are not available for either. Insurance coverage varies by plan — some plans may favor one over the other based on formulary tier.